Inventor

Dean Sheppard

Inventor

Oakland, CA, US

Overview

23→

Patents

1999–2020

Patent span

Human necessities

Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Kprimary

C07KPeptides28%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%

A61KPreparations for medical, dental or toiletry purposes15%

G01NInvestigating or analysing materials by determining their chemical or physical properties7%

A01KAnimal husbandry6%

C07DHeterocyclic compounds4%

Y10TTechnical subjects covered by former us classification3%

A23GCocoa1%

A23KFodder1%

A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for1%

PatentTitleYear

10,836,720Inhibitors of integrin alpha 5 beta 1 and methods of use2020 10,597,455Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin2020 10,214,522Anti-alphavbeta1 integrin inhibitors and methods of use2019 10,131,658Anti-alphavbeta1 integrin compounds and methods2018 10,087,252Methods and compositions for treating and preventing disease associated with avb5 integrin2018 10,005,838Milk fat globule epidermal growth factor 8 regulates fatty acid uptake2018 9,969,804Methods and compositions for treating and preventing disease associated with alpha-V beta-8 integrin2018 9,745,376'Anti-Î±Î½Î²6 antibodies'2017 8,153,126'Anti-Î±vÎ²6 antibodies'2012 7,815,908'Methods and compositions for treating and preventing disease associated with Î±VÎ²5 integrin'2010 7,544,358'Treatment of acute lung injury, fibrosis and metastasis with antagonists of Î±vÎ²6'2009 7,465,449'Anti-Î±vÎ²6 antibodies'2008 7,291,475'Methods of expressing integrin Î²6 subunits'2007 7,150,871'Treatment of acute lung injury, fibrosis and metastasis with antagonists of Î±vÎ²6'2006 6,787,322'Methods of expressing integrin 6 subunits'2004 6,752,244'Apparatus for draining fluids from vehicles'2004 6,692,741'Treatment of acute lung injury and fibrosis with antagonists of 6-specific antibodies'2004 6,639,056'Antibodies specifically reactive with integrin 6 subunits'2003 6,596,277'Methods of decreasing cell adhesion'2003 6,576,432'Methods of detecting v6 ligands'2003 6,339,148'Isolated nucleic acid encoding an integrin -subunit'2002 6,316,601'Antibodies specific for .beta.6 integrins'2001 5,962,643'Integrin .beta. subunit and uses thereof'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2020Patents assigned to UNIV CALIFORNIA (21)· patent assignee history

1999–2020Based in Oakland, CA, US· patent location history

2004Based in Calgary, CA· patent location history

2008Patents assigned to BIOGEN IDEC INC (1)· patent assignee history

2012–2018Patents assigned to SHEPPARD DEAN (2)· patent assignee history

2017Patents assigned to BIOGEN MA INC (1)· patent assignee history

2018Patents assigned to ATAKILIT AMHA (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UNIV CALIFORNIA	21	1999–2020
SHEPPARD DEANself	2	2012–2018
ATAKILIT AMHA	1	2018
BIOGEN IDEC INC	1	2008
BIOGEN MA INC	1	2017

Locations

Location	Patents	Span
Oakland, California, US	22	1999–2020
Calgary, CA	1	2004